By 2050, an estimated 13 million Americans will have Alzheimer’s disease.1 But despite its prevalence, there’s no known cure and its causes are hotly debated. While it’s often said that an accumulation of amyloid beta plaques underlies Alzheimer’s, there appears to be more to the story. It’s been suggested the plaques may be a symptom… Read More »
Here, I interview repeat guest Morley Robbins, MBA, CHC,1 founder of the Magnesium Advocacy Group and author of “Cu-RE Your Fatigue: The Root Cause and How to Fix It on Your Own.” While we’ve discussed the topic of iron and copper before, the percentage of doctors and natural medical clinicians who understand his work is… Read More »
This article was previously published December 2, 2020, and has been updated with new information. The evidence continues to accumulate that avoiding toxic industrially processed seed oils, often referred to as “vegetable oils,” is essential to protecting your health, and recent research adds dietary iron to the increased health risks as well, particularly for those… Read More »
Many people are aware of their risks with their food and appliances in the age of information and health consciousness. Cookware is no exception. With many consumers preferring green and clean pans, the question stands: is cooking with cast-iron healthy? Cookware Safety Not all cookware is made alike; that being said, there are degrees of… Read More »
BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer® (ferric carboxymaltose injection), an iron replacement product, for the treatment of iron deficiency anemia (IDA) in adult… Read More »
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »